TCA
EMN icon

Transcend Capital Advisors’s Eastman Chemical EMN Stock Holding History

Transcend Capital Advisors’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,480
Closed -$247K – 503
2022
Q3 		$247K Sell
3,480
-22
-0.6% -$1.98K 0.03% 399
2022
Q2 		$314K Buy
3,502
+4
+0.1% +$414 0.03% 370
2022
Q1 		$392K Buy
+3,498
New +$410K 0.04% 357

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Transcend Capital Advisors's EMN Position: Q4 2022 in Review

Transcend Capital Advisors sold out of Eastman Chemical (EMN) in Q4 2022, closing a stake of 3,480 shares — an estimated $247K sold.

Transcend Capital Advisors first reported a position in EMN in Q1 2022 and held it in 3 quarters. The position peaked at $392K in Q1 2022. 706 funds tracked by Wall St. Rank hold EMN as of Q4 2022.

  • Transcend Capital Advisors reported no remaining Eastman Chemical position as of Q4 2022 after selling out during the quarter.
  • Transcend Capital Advisors sold 3,480 Eastman Chemical shares in Q4 2022, an estimated $247K.
  • Transcend Capital Advisors first reported a position in Eastman Chemical in Q1 2022 and held it in 3 quarters.
  • Transcend Capital Advisors's Eastman Chemical position peaked at $392K in Q1 2022.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2022.

Based on Transcend Capital Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.